Drugs causing immune haemolytic anaemia: results from the Berlin Case-Control Surveillance Study (FAKOS)

Elisabeth Bronder, Hanife Kurtal, Andreas Klimpel, Frank Andersohn, Michael Thomae, Hubert Schrezenmeier, Martin Hildebrandt, Ernst Späth-Schwalbe, Andreas Grüneisen, Beate Mayer, Abdulgabar Salama & Edeltraut Garbe
Background: Drug-induced immune haemolytic anaemia (DIIHA) is a rare but serious condition with an estimated incidence of 1 case/million/year. More than 130 drugs have been implicated as a cause, but reports are often incomplete. Objectives: To characterize the spectrum of drugs associa[for full text, please go to the a.m. URL]